A prospective, randomised, controlled trial using a Mg-hydroxyapatite - demineralized bone matrix nanocomposite in tibial osteotomy

Dante Dallari, Lucia Savarino, Ugo Albisinni, Piermaria Fornasari, Alberto Ferruzzi, Nicola Baldini, Sandro Giannini

Research output: Contribution to journalArticle

Abstract

We in vivo investigated the bone healing ability of a nanocomposite (DBSint®), constituted by biomimetic nano-structured Mg-hydroxyapatite (SINTlife®) and human demineralized bone matrix. Thirty-one subjects undergoing high tibial osteotomy for genu varus were randomly assigned to three groups: during surgery, DBSint® was inserted into nine patients, SINTlife® in thirteen patients and lyophilised bone chips, that is the routine surgery, in nine subjects. As outcome measures, clinical, radiographic and histomorphometry scores were calculated. The osseointegration was evaluated by imaging six weeks, three, six and twelve months after surgery. At six-week follow-up, DBSint® showed a significantly higher osseointegration rate in comparison with lyophilised bone chips (p = 0.008). At the same follow-up, CT-guided bone biopsies were obtained and analysed by histomorphometry: a good osteogenetic potential was demonstrated with DBSint®, as well as with SINTlife® and controls. Unresorbed material was evident with DBSint® and SINTlife®, with a significantly higher percentage in SINTlife® group. At 1-year follow-up, DBSint® was demonstrated as effective and safe as SINTlife® and lyophilized bone chips. More significant results could be obtained by continuing the clinical trial, by increasing the patient number and the study power. Eventually, the role of non-resorbed graft remnants is still unclear and requires further investigation.

Original languageEnglish
Pages (from-to)72-79
Number of pages8
JournalBiomaterials
Volume33
Issue number1
DOIs
Publication statusPublished - Jan 2012

Fingerprint

Nanocomposites
Bone Matrix
Durapatite
Osteotomy
Hydroxyapatite
Bone
Randomized Controlled Trials
Bone and Bones
Osseointegration
Surgery
Genu Varum
Biomimetics
Biopsy
Grafts
Outcome Assessment (Health Care)
Clinical Trials
Transplants
Imaging techniques

Keywords

  • Bone healing
  • Demineralized bone matrix
  • Nano-structured Mg-hydroxyapatite
  • Osteotomy

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

A prospective, randomised, controlled trial using a Mg-hydroxyapatite - demineralized bone matrix nanocomposite in tibial osteotomy. / Dallari, Dante; Savarino, Lucia; Albisinni, Ugo; Fornasari, Piermaria; Ferruzzi, Alberto; Baldini, Nicola; Giannini, Sandro.

In: Biomaterials, Vol. 33, No. 1, 01.2012, p. 72-79.

Research output: Contribution to journalArticle

@article{91d7c863f5f3435ca0d83a8bd7d98257,
title = "A prospective, randomised, controlled trial using a Mg-hydroxyapatite - demineralized bone matrix nanocomposite in tibial osteotomy",
abstract = "We in vivo investigated the bone healing ability of a nanocomposite (DBSint{\circledR}), constituted by biomimetic nano-structured Mg-hydroxyapatite (SINTlife{\circledR}) and human demineralized bone matrix. Thirty-one subjects undergoing high tibial osteotomy for genu varus were randomly assigned to three groups: during surgery, DBSint{\circledR} was inserted into nine patients, SINTlife{\circledR} in thirteen patients and lyophilised bone chips, that is the routine surgery, in nine subjects. As outcome measures, clinical, radiographic and histomorphometry scores were calculated. The osseointegration was evaluated by imaging six weeks, three, six and twelve months after surgery. At six-week follow-up, DBSint{\circledR} showed a significantly higher osseointegration rate in comparison with lyophilised bone chips (p = 0.008). At the same follow-up, CT-guided bone biopsies were obtained and analysed by histomorphometry: a good osteogenetic potential was demonstrated with DBSint{\circledR}, as well as with SINTlife{\circledR} and controls. Unresorbed material was evident with DBSint{\circledR} and SINTlife{\circledR}, with a significantly higher percentage in SINTlife{\circledR} group. At 1-year follow-up, DBSint{\circledR} was demonstrated as effective and safe as SINTlife{\circledR} and lyophilized bone chips. More significant results could be obtained by continuing the clinical trial, by increasing the patient number and the study power. Eventually, the role of non-resorbed graft remnants is still unclear and requires further investigation.",
keywords = "Bone healing, Demineralized bone matrix, Nano-structured Mg-hydroxyapatite, Osteotomy",
author = "Dante Dallari and Lucia Savarino and Ugo Albisinni and Piermaria Fornasari and Alberto Ferruzzi and Nicola Baldini and Sandro Giannini",
year = "2012",
month = "1",
doi = "10.1016/j.biomaterials.2011.09.029",
language = "English",
volume = "33",
pages = "72--79",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - A prospective, randomised, controlled trial using a Mg-hydroxyapatite - demineralized bone matrix nanocomposite in tibial osteotomy

AU - Dallari, Dante

AU - Savarino, Lucia

AU - Albisinni, Ugo

AU - Fornasari, Piermaria

AU - Ferruzzi, Alberto

AU - Baldini, Nicola

AU - Giannini, Sandro

PY - 2012/1

Y1 - 2012/1

N2 - We in vivo investigated the bone healing ability of a nanocomposite (DBSint®), constituted by biomimetic nano-structured Mg-hydroxyapatite (SINTlife®) and human demineralized bone matrix. Thirty-one subjects undergoing high tibial osteotomy for genu varus were randomly assigned to three groups: during surgery, DBSint® was inserted into nine patients, SINTlife® in thirteen patients and lyophilised bone chips, that is the routine surgery, in nine subjects. As outcome measures, clinical, radiographic and histomorphometry scores were calculated. The osseointegration was evaluated by imaging six weeks, three, six and twelve months after surgery. At six-week follow-up, DBSint® showed a significantly higher osseointegration rate in comparison with lyophilised bone chips (p = 0.008). At the same follow-up, CT-guided bone biopsies were obtained and analysed by histomorphometry: a good osteogenetic potential was demonstrated with DBSint®, as well as with SINTlife® and controls. Unresorbed material was evident with DBSint® and SINTlife®, with a significantly higher percentage in SINTlife® group. At 1-year follow-up, DBSint® was demonstrated as effective and safe as SINTlife® and lyophilized bone chips. More significant results could be obtained by continuing the clinical trial, by increasing the patient number and the study power. Eventually, the role of non-resorbed graft remnants is still unclear and requires further investigation.

AB - We in vivo investigated the bone healing ability of a nanocomposite (DBSint®), constituted by biomimetic nano-structured Mg-hydroxyapatite (SINTlife®) and human demineralized bone matrix. Thirty-one subjects undergoing high tibial osteotomy for genu varus were randomly assigned to three groups: during surgery, DBSint® was inserted into nine patients, SINTlife® in thirteen patients and lyophilised bone chips, that is the routine surgery, in nine subjects. As outcome measures, clinical, radiographic and histomorphometry scores were calculated. The osseointegration was evaluated by imaging six weeks, three, six and twelve months after surgery. At six-week follow-up, DBSint® showed a significantly higher osseointegration rate in comparison with lyophilised bone chips (p = 0.008). At the same follow-up, CT-guided bone biopsies were obtained and analysed by histomorphometry: a good osteogenetic potential was demonstrated with DBSint®, as well as with SINTlife® and controls. Unresorbed material was evident with DBSint® and SINTlife®, with a significantly higher percentage in SINTlife® group. At 1-year follow-up, DBSint® was demonstrated as effective and safe as SINTlife® and lyophilized bone chips. More significant results could be obtained by continuing the clinical trial, by increasing the patient number and the study power. Eventually, the role of non-resorbed graft remnants is still unclear and requires further investigation.

KW - Bone healing

KW - Demineralized bone matrix

KW - Nano-structured Mg-hydroxyapatite

KW - Osteotomy

UR - http://www.scopus.com/inward/record.url?scp=82855161331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82855161331&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2011.09.029

DO - 10.1016/j.biomaterials.2011.09.029

M3 - Article

C2 - 21955688

AN - SCOPUS:82855161331

VL - 33

SP - 72

EP - 79

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 1

ER -